Disc Medicine (IRON) Gains from Investment Securities (2020 - 2026)
Disc Medicine (IRON) reported Gains from Investment Securities of $12000.0 for Q1 2026, up 180.0% year-over-year from $4285.7 in Q1 2025, and down 99.96% quarter-over-quarter from $30.2 million in Q4 2025.
Disc Medicine (IRON) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Gains from Investment Securities data on file, last reported at $12000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $12000.0, up 180.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.2 million (up 321.93% YoY), and the FY2025 annual result was $3.3 million, up 13.9% from the prior year.
- Gains from Investment Securities eased to $12000.0 in Q1 2026 per IRON's latest filing, from $30.2 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $30.2 million in Q4 2025 and troughed at -$15000.0 in Q4 2024.
- A 5-year average of $3.6 million and a median of $983949.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities slumped 100.21% in 2024, then surged 201433.33% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $1.2 million in 2022, then jumped by 520.49% to $7.2 million in 2023, then tumbled by 100.21% to -$15000.0 in 2024, then surged by 201433.33% to $30.2 million in 2025, then plunged by 99.96% to $12000.0 in 2026.
- Business Quant data shows IRON's Gains from Investment Securities at $12000.0 in Q1 2026, $30.2 million in Q4 2025, and $15000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 30.20 Mn |
| Dec 31, 2025 | 30.20 Mn |
| Jun 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | 2.97 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 696,533.00 |
| Jun 30, 2024 | 696,533.00 |
| Dec 31, 2023 | 7.19 Mn |
| Dec 31, 2023 | 7.19 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 70,430.00 |
| Jun 30, 2023 | 70,430.00 |